The inclusion criteria were: Original research articles, Studies investigating ROS or free radical-related mechanisms in ovarian cancer, Studies that included in vitro experiments, whether alone or in combination with in vivo data, and Studies in which ROS (or ROS-generating/redox-regulatory pathways) were experimentally linked to pro-tumorigenic outcomes, including enhanced proliferation/survival, angiogenic signaling, EMT/migration/invasion, or therapeutic resistance, and/or in which ROS suppression (e.g., antioxidants, inhibition of ROS sources, or genetic perturbation of redox regulators) attenuated these malignant phenotypes
[PMID: 30081344] PubMed record related to this compound for laboratory literature review
There is no comparison between a supplement like Lemme Reset and GLP-1 medications
Epithalon can potentially extend the life span of cells and enhance overall cellular function
If you want to learn more about the side effects and safety of drugs like Ozempic and Wegovy, see our article here